SkinHealth Systems Inc. SKIN
SkinHealth Systems Inc. (Nasdaq: SKIN) is a dermatology consumer health company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Hydrafacial Syndeo delivery system and consumables | skin health (aesthetic) | device-combination | NA_NON_THERAPEUTIC |
| SkinStylus microneedling | aesthetic skin treatment | device-combination | NA_NON_THERAPEUTIC |
| HydraScalp powered by Keravive | scalp and hair appearance | unclear | NA_NON_THERAPEUTIC |
Recent results and decisions
- Oct 14, 2026n/a SkinHealth Systems implements 1-for-20 reverse stock split to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
The Reverse Stock Split is intended to help the Company regain compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).
Filing
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other dermatology companies
- Spectral AI, Inc. MDAI
- SANUWAVE Health, Inc. SNWV
- Sonoma Pharmaceuticals, Inc. SNOA
- Nexgel, Inc. NXGL
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.